Literature DB >> 24705192

An infected enlarging abdominal aortic aneurysm after acute cholecystitis.

Sang Y Hwang1, James M F Clarke2, Tjun Y Tang3.   

Abstract

INTRODUCTION: An abdominal aortic aneurysm (AAA) infection is rare and can be difficult to manage, with high morbidity and mortality. We present a patient who suffered an infected AAA after undergoing a laparoscopic cholecystectomy and discuss the surgical management options. PRESENTATION OF CASE: A 69-year-old male presents with a rapidly enlarging AAA 4 weeks following laparoscopic cholecystectomy. He was managed with open debridement, washout and repair of the aneurysm, but suffered ongoing sequelae of Escherichia coli sepsis. DISCUSSION: The options for surgical management of infected AAA include open, endovascular and combined approaches. Recent papers report successful use of endovascular repair of infected AAAs but this is an ongoing area of research.
CONCLUSION: Infection of an AAA is associated with high mortality and long-term morbidity and requires optimal treatment. Surgical options include open debridement and repair, endovascular aneurysm repair (EVAR) or a combined approach.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Abdominal aortic aneurysm; Cholecystitis; Infection

Year:  2014        PMID: 24705192      PMCID: PMC4008856          DOI: 10.1016/j.ijscr.2014.02.012

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  10 in total

1.  What is the best treatment for primary infected aortic aneurysms?

Authors:  C P Gibbons
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-08-19       Impact factor: 7.069

2.  Surgical treatment of infected aneurysms and pseudoaneurysms of the thoracic and abdominal aorta.

Authors:  Albert C W Ting; Stephen W K Cheng; Pei Ho; Jensen T C Poon; James H L Tsu
Journal:  Am J Surg       Date:  2005-02       Impact factor: 2.565

3.  The feasibility of endovascular aortic repair strategy in treating infected aortic aneurysms.

Authors:  Chung-Dann Kan; Hsu-Ting Yen; Chung-Ben Kan; Yu-Jen Yang
Journal:  J Vasc Surg       Date:  2011-11-01       Impact factor: 4.268

4.  Primary infected abdominal aortic aneurysm: surgical procedures, early mortality rates, and a survey of the prevalence of infectious organisms over a 30-year period.

Authors:  Hideaki Maeda; Hisaki Umezawa; Masakazu Goshima; Tsutomu Hattori; Tetsuya Nakamura; Tomofumi Umeda; Motomi Shiono
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

5.  Infected aneurysms of the suprarenal abdominal aorta.

Authors:  Ron-Bin Hsu; Chung-I Chang; Chih-Yang Chan; I-Hui Wu
Journal:  J Vasc Surg       Date:  2011-07-29       Impact factor: 4.268

6.  In situ polytetrafluoroethylene graft bypass for primary infected aneurysm of the infrarenal abdominal aorta.

Authors:  Tae-Won Kwon; Hyang-Kyoung Kim; Ki-Myung Moon; Yong-Pil Cho; Sang-Jun Park
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

7.  Surgical mortality in patients with infected aortic aneurysms.

Authors:  Anthony J Fillmore; R James Valentine
Journal:  J Am Coll Surg       Date:  2003-03       Impact factor: 6.113

8.  Mycotic pseudoaneurysm of the ascending aorta caused by Escherichia coli.

Authors:  Mitsuhiro Yano; Takahiro Hayase; Koji Furukawa; Kunihide Nakamura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-10-12

9.  Is endovascular repair of mycotic aortic aneurysms a durable treatment option?

Authors:  R E Clough; S A Black; O T Lyons; H A Zayed; R E Bell; T Carrell; M Waltham; T Sabharwal; P R Taylor
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-02-10       Impact factor: 7.069

10.  Multi-resistant Escherichia coli and mycotic aneurysm: two case reports.

Authors:  John F McCann; Azhar Fareed; Sukanya Reddy; John Cheesbrough; Neil Woodford; Sally Lau
Journal:  J Med Case Rep       Date:  2009-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.